Timing of Resistance Exercise in Type 1 Diabetes (T-REX)

July 27, 2023 updated by: Dr. Ebaa Al Ozairi, Dasman Diabetes Institute

Timing of Resistance Exercise, Glucose Control and Exercise Adaptations in People With Type 1 Diabetes: a Randomised-controlled Trial

The aims of the current study are

  1. to compare the effects of acute morning and afternoon resistance exercise on blood glucose levels in people with type 1 diabetes.
  2. to compare the effects of morning and afternoon resistance exercise training on cardiometabolic health outcomes in people with type 1 diabetes

Study Overview

Study Type

Interventional

Enrollment (Estimated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Kuwait City, Kuwait, 15462
        • Recruiting
        • Dasman Diabetes Institute
        • Contact:
          • Ebaa AlOZairi
        • Principal Investigator:
          • Ebaa AlOzairi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Physician confirmed type 1 diabetes for at least 1 year
  • Stable insulin therapy for 3 months prior to the study

Exclusion Criteria:

  • BMI of 45 or higher
  • BP of 160/100mmHg or higher
  • autonomic neuropathy
  • severe proliferative retinopathy
  • joint or limb injuries preventing weight-bearing activity
  • autonomic neuropathy
  • severe proliferative retinopathy
  • any other medical condition that prevents participants from exercising safely.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
Habitual physical activity
Participants will be asked to maintain their normal activity levels
Active Comparator: Morning exercise
Exercise training between 6-10am
Between 6-10am participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)
Active Comparator: Afternoon exercise
Exercise training between 4-8pm
Between 4-8pm participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle strength
Time Frame: Change from baseline to 12 weeks
Sum of one repetition maximum for the 7 resistance exercise
Change from baseline to 12 weeks
Change in interstitial glucose time in range
Time Frame: Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Interstitial glucose time in range (3.9-10mmol/L) measured via continuous glucose monitoring
Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in appendicular skeletal muscle mass
Time Frame: Change from baseline to 12 weeks
Measured by DEXA
Change from baseline to 12 weeks
Change in whole body fat mass
Time Frame: Change from baseline to 12 weeks
Measured by DEXA
Change from baseline to 12 weeks
Change in physical function
Time Frame: Change from baseline to 12 weeks
Measured by the short performance physical battery
Change from baseline to 12 weeks
Change in HbA1c
Time Frame: Change from baseline to 12 weeks
HbA1c concentration
Change from baseline to 12 weeks
Change in interstitial glucose average
Time Frame: Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Interstitial average glucose measured via continuous glucose monitoring
Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Change in interstitial glucose variability
Time Frame: Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Interstitial glucose variability measured via continuous glucose monitoring
Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Change in interstitial glucose time in hypoglycaemia
Time Frame: Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Interstitial glucose time in range (<3.9mmol/L) measured via continuous glucose monitoring
Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Change in interstitial glucose time in hyperglycaemia
Time Frame: Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session
Interstitial glucose time in range (>10mmol/L) measured via continuous glucose monitoring
Change from 6 hours before (baseline) to 6 hours after (post-exercise) an exercise training session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

May 10, 2023

First Submitted That Met QC Criteria

May 22, 2023

First Posted (Actual)

June 1, 2023

Study Record Updates

Last Update Posted (Actual)

July 28, 2023

Last Update Submitted That Met QC Criteria

July 27, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 Diabetes

Clinical Trials on Habitual physical activity levels

3
Subscribe